Claus Oster‐Schmidt

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo

Thomas Dirschka, Peter Radny, R. Dominicus et al. · British Journal of Dermatology · 2011 · 181 citations

Medicine, Dermatology, Pharmacology +15

Long‐term (6 and 12 months) follow‐up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF‐200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis

Thomas Dirschka, Peter Radny, R. Dominicus et al. · British Journal of Dermatology · 2012 · 102 citations · Full text

Medicine, Dermatology, Ophthalmology +14

Nonmelanoma skin cancer – from actinic keratosis to cutaneous squamous cell carcinoma

Lutz Schmitz, Claus Oster‐Schmidt, Eggert Stockfleth · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2018 · 35 citations

Medicine, Dermatology, Oncology +17

Two cases of squamous cell carcinoma treated with topical imiquimod 5%

Claus Oster‐Schmidt · Journal of the European Academy of Dermatology and Venereology · 2003 · 26 citations

Medicine, Dermatology, Oncology +13

Imiquimod: A New Possibility for Treatment-Resistant Verrucae Planae

Claus Oster‐Schmidt · Archives of Dermatology · 2001 · 23 citations

Life Sciences, Pharmacotherapy, Immunotherapy +2